Anish Bhatnagar

832 total citations
30 papers, 585 citations indexed

About

Anish Bhatnagar is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Molecular Biology. According to data from OpenAlex, Anish Bhatnagar has authored 30 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 8 papers in Genetics and 6 papers in Molecular Biology. Recurrent topics in Anish Bhatnagar's work include Genetic Syndromes and Imprinting (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Histone Deacetylase Inhibitors Research (4 papers). Anish Bhatnagar is often cited by papers focused on Genetic Syndromes and Imprinting (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Histone Deacetylase Inhibitors Research (4 papers). Anish Bhatnagar collaborates with scholars based in United States, United Kingdom and India. Anish Bhatnagar's co-authors include Roland Hustinx, Harvey A. Ziessman, Robin J. Smith, François Bénard, Abass Alavi, Frank H. Valone, Sunil Sreedharan, Harold Keer, Bert L. Lum and David Irwin and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Anish Bhatnagar

29 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anish Bhatnagar United States 11 230 164 132 103 60 30 585
Lijuan Fang China 12 320 1.4× 149 0.9× 62 0.5× 141 1.4× 22 0.4× 42 645
Virgil Gadaleanu Sweden 16 312 1.4× 164 1.0× 100 0.8× 274 2.7× 26 0.4× 24 828
Chun Yang China 8 127 0.6× 52 0.3× 110 0.8× 70 0.7× 98 1.6× 31 665
Edwige Tellier France 13 401 1.7× 79 0.5× 38 0.3× 76 0.7× 56 0.9× 25 786
Robert Rzepko Poland 16 205 0.9× 200 1.2× 53 0.4× 125 1.2× 27 0.5× 44 711
F. Pontillon France 9 262 1.1× 71 0.4× 90 0.7× 41 0.4× 38 0.6× 11 606
Laurent Martin France 11 90 0.4× 62 0.4× 80 0.6× 108 1.0× 25 0.4× 24 435
Frédéric Commo France 13 247 1.1× 273 1.7× 36 0.3× 226 2.2× 22 0.4× 16 774
Toru Igarashi Japan 16 261 1.1× 161 1.0× 49 0.4× 79 0.8× 14 0.2× 47 708
Leszek Kozłowski Poland 12 256 1.1× 268 1.6× 29 0.2× 85 0.8× 15 0.3× 34 683

Countries citing papers authored by Anish Bhatnagar

Since Specialization
Citations

This map shows the geographic impact of Anish Bhatnagar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anish Bhatnagar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anish Bhatnagar more than expected).

Fields of papers citing papers by Anish Bhatnagar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anish Bhatnagar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anish Bhatnagar. The network helps show where Anish Bhatnagar may publish in the future.

Co-authorship network of co-authors of Anish Bhatnagar

This figure shows the co-authorship network connecting the top 25 collaborators of Anish Bhatnagar. A scholar is included among the top collaborators of Anish Bhatnagar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anish Bhatnagar. Anish Bhatnagar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Michael, et al.. (2025). The burden of illness in Prader-Willi syndrome: a systematic literature review. Orphanet Journal of Rare Diseases. 20(1). 374–374.
2.
Kumar, Akshay, et al.. (2024). A Review and Analysis of IoT Enabled Smart Transportation Using Machine Learning Techniques. International Journal of Transport Development and Integration. 8(1). 61–77. 2 indexed citations
3.
4.
Strong, Theresa V., Jennifer Miller, Shawn E. McCandless, et al.. (2024). Behavioral changes in patients with Prader-Willi syndrome receiving diazoxide choline extended-release tablets compared to the PATH for PWS natural history study. Journal of Neurodevelopmental Disorders. 16(1). 22–22. 3 indexed citations
5.
Butler, Merlin G., et al.. (2023). Chromosomal Microarray Study in Prader-Willi Syndrome. International Journal of Molecular Sciences. 24(2). 1220–1220. 4 indexed citations
6.
Bhatnagar, Anish, Haitham Khraishah, Jennifer Lee, et al.. (2020). Rapid implementation of a mechanical chest compression device for in-hospital cardiac arrest during the COVID-19 pandemic. Resuscitation. 156. 4–5. 3 indexed citations
7.
Bhatnagar, Anish, Jennifer Lee, Haitham Khraishah, et al.. (2020). Abstract 110: Introduction of a Mechanical Chest Compression Device for In-hospital Cardiac Arrest During the Covid-19 Pandemic. Circulation. 142(Suppl_4). 1 indexed citations
8.
Campbell, Robert A., Zechariah G. Franks, Anish Bhatnagar, et al.. (2017). Granzyme A in Human Platelets Regulates the Synthesis of Proinflammatory Cytokines by Monocytes in Aging. The Journal of Immunology. 200(1). 295–304. 62 indexed citations
9.
10.
Killick, Emma, J.A. Bennett, Andrew Bates, et al.. (2014). 26 Treatment and outcome in epidermal growth factor receptor mutant non-small cell lung cancer: A retrospective audit across four NHS trusts. Lung Cancer. 83. S10–S11. 1 indexed citations
11.
Casale, Thomas B., et al.. (2011). Nasal carbon dioxide for the symptomatic treatment of perennial allergic rhinitis. Annals of Allergy Asthma & Immunology. 107(4). 364–370. 8 indexed citations
12.
Tzabazis, Alexander, et al.. (2010). Trigeminal antihyperalgesic effect of intranasal carbon dioxide. Life Sciences. 87(1-2). 36–41. 10 indexed citations
13.
Bhatnagar, Anish, et al.. (2005). Radio-labeling of Ethambutol with Technetium-99m and its evaluation for detection of tuberculosis. World Journal of Nuclear Medicine. 4(1). 35–46. 5 indexed citations
14.
Chong, Geoff, Anish Bhatnagar, David Cunningham, et al.. (2005). Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancer. Annals of Oncology. 17(3). 437–442. 26 indexed citations
15.
Digumarti, Raghunadharao, P. Koralewski, Piotr Serwatowski, et al.. (2005). P-560 A randomized phase II study of plvanex and docetaxel comparedto docetaxell monotherapy In patients with previously treated advanced NSCLC. Lung Cancer. 49. S265–S265. 3 indexed citations
16.
Reid, Tony, Frank H. Valone, David Irwin, et al.. (2004). Phase II trial of the histone deacetylase inhibitor pivaloyloxymethyl butyrate (Pivanex, AN-9) in advanced non-small cell lung cancer. Lung Cancer. 45(3). 381–386. 138 indexed citations
17.
Peck, Ronald A., Matthew W. Harding, Yow‐Ming Wang, et al.. (2001). Phase I and Pharmacokinetic Study of the Novel MDR1 and MRP1 Inhibitor Biricodar Administered Alone and in Combination With Doxorubicin. Journal of Clinical Oncology. 19(12). 3130–3141. 82 indexed citations
18.
Bhatnagar, Anish, et al.. (2000). Nuclear imaging methods for non-invasive drug monitoring. Advanced Drug Delivery Reviews. 41(1). 41–54. 22 indexed citations
19.
Hustinx, Roland, François Bénard, Anish Bhatnagar, et al.. (2000). Impact of attenuation correction on the accuracy of FDG-PET in patients with abdominal tumors: a free-response ROC analysis. European Journal of Nuclear Medicine and Molecular Imaging. 27(9). 1365–1371. 21 indexed citations
20.
Hustinx, Roland, Robin J. Smith, François Bénard, Anish Bhatnagar, & Abass Alavi. (1999). Can the standardized uptake value characterize primary brain tumors on FDG-PET?. European Journal of Nuclear Medicine and Molecular Imaging. 26(11). 1501–1509. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lijuan Fang Breakdown of academic impact, for papers by Virgil Gadaleanu Breakdown of academic impact, for papers by Chun Yang Breakdown of academic impact, for papers by Edwige Tellier Breakdown of academic impact, for papers by Robert Rzepko Breakdown of academic impact, for papers by F. Pontillon Breakdown of academic impact, for papers by Laurent Martin Breakdown of academic impact, for papers by Frédéric Commo Breakdown of academic impact, for papers by Toru Igarashi Breakdown of academic impact, for papers by Leszek Kozłowski
Rankless by CCL
2026